GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PeopleBio Co Ltd (XKRX:304840) » Definitions » Debt-to-Revenue

PeopleBio Co (XKRX:304840) Debt-to-Revenue : 0.51 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PeopleBio Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

PeopleBio Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩530 Mil. PeopleBio Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩999 Mil. PeopleBio Co's annualized Revenue for the quarter that ended in Mar. 2024 was ₩2,978 Mil. PeopleBio Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.51.


PeopleBio Co Debt-to-Revenue Historical Data

The historical data trend for PeopleBio Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeopleBio Co Debt-to-Revenue Chart

PeopleBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial 0.37 0.43 23.82 3.68 0.57

PeopleBio Co Quarterly Data
Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.80 2.98 3.13 0.49 0.51

Competitive Comparison of PeopleBio Co's Debt-to-Revenue

For the Medical Devices subindustry, PeopleBio Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PeopleBio Co's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PeopleBio Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where PeopleBio Co's Debt-to-Revenue falls into.



PeopleBio Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

PeopleBio Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1440.702 + 1113.704) / 4452.858
=0.57

PeopleBio Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(529.649 + 999.023) / 2977.856
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


PeopleBio Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of PeopleBio Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PeopleBio Co (XKRX:304840) Business Description

Traded in Other Exchanges
N/A
Address
242 Pangyo-ro, 6th Floor, PDC C-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487
PeopleBio Co Ltd is a biotechnology company. The company is engaged in the business of developing diagnostic products for neurodegenerative diseases. The company's technology, Multimer Detection System (MDS), helps in detecting protein misfolding diseases like Alzheimer's disease, Parkinson's disease, and Creutzfeldt-Jakob's disease.

PeopleBio Co (XKRX:304840) Headlines

No Headlines